Skip to main content

Table 1 The characteristics of small cell lung cancer patients

From: Reconsidering N component of cancer staging for T1-2N0-2M0 small-cell lung cancer: a retrospective study based on multicenter cohort

 

SEER

MCDB

Total

 

n = 849

n = 307

Sex

Male

369 (43.5%)

268 (87.3%)

Female

480 (56.5%)

39 (12.7%)

Age

≤ 65

369 (43.5%)

182 (59.3%)

> 65

480 (56.5%)

125 (40.7%)

Surgery

Lobectomy/ pneumonectomy

655 (77.1%)

277 (90.2%)

Sub-lobectomy

194 (22.9%)

30 (9.8%)

Radiotherapy

None

545 (64.2%)

263 (85.7%)

Yes

289 (34.0%)

44 (14.3%)

Unknown

15 (1.8%)

0 (0%)

Chemotherapy

None

273 (32.2%)

100 (32.6%)

Yes

576 (67.8%)

207 (67.4%)

Location

Upper lobe

510 (60.1%)

170 (55.4%)

Lower lobe

263 (31.0%)

110 (35.8%)

Other/ unknown

76 (9.0%)

27 (8.8%)

Grade

I-II

47 (5.5%)

0 (0%)

III

312 (36.7%)

82 (26.7%)

IV

249 (29.3%)

66 (21.5%)

Unknown

241 (28.5)

159 (51.8)

Examined lymph nodes

≤ 3

195 (23.0%)

34 (11.1%)

> 3

654 (77.0%)

273 (88.9%)

Tumor size

≤ 3.0 cm

649 (76.4%)

192 (62.5%)

> 3.0 cm

200 (23.6%)

115 (37.5%)

pN classification

pN0

533 (62.8%)

149 (48.5%)

pN1

174 (20.5%)

51 (16.6%)

pN2

142 (16.7%)

107 (34.9%)

Lymph node ratio

≤ 0.14

628 (74.0%)

209 (68.1%)

> 0.14

221 (26.0%)

98 (31.9%)

New pN classification

New pN#1

402 (47.3%)

124 (40.4%)

New pN#2

226 (26.6%)

86 (28.0%)

New pN#3

221 (26.1%)

97 (31.6%)

  1. SEER: Surveillance, Epidemiology, and End Results, MCDB: multi-center database; pN: pathological nodal